Fibrinolysis for patients with intermediate-risk pulmonary embolism.

Meyer, Guy; Vicaut, Eric; Danays, Thierry; Agnelli, Giancarlo; Becattini, Cecilia; Beyer-Westendorf, Jan; Bluhmki, Erich; Bouvaist, Helene; Brenner, Benjamin; Couturaud, Francis; Dellas, Claudia; Empen, Klaus; Franca, Ana; Galiè, Nazzareno; Geibel, Annette; Z Goldhaber, Samuel; Jimenez, David; Kozak, Matija; Kupatt, Christian; Kucher, Nils; M Lang, Irene; Lankeit, Mareike; Meneveau, Nicolas; Pacouret, Gerard; Palazzini, Massimiliano; Petris, Antoniu; Pruszczyk, Piotr; Rugolotto, Matteo; Salvi, Aldo; Schellong, Sebastian; Sebbane, Mustapha; Sobkowicz, Bozena; S Stefanovic, Branislav; Thiele, Holger; Torbicki, Adam; Verschuren, Franck; V Konstantinides, Stavros; Investigators, PEITHO

doi:10.1056/NEJMoa1302097

Public

Fibrinolysis for patients with intermediate-risk pulmonary embolism.

Shared by NobleBlocks on Apr 10, 2014 • 12:00 AM UTC

Authors:

Guy Meyer

Eric Vicaut

Thierry Danays

Abstract

BACKGROUND: The role of fibrinolytic therapy in patients with intermediate-risk pulmonary embolism is controversial. METHODS: In a randomized, double-blind trial, we compared tenecteplase plus heparin with placebo plus heparin in normotensive patients with intermediate-risk pulmonary embolism. Eligi...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!